v4.25 (#1200)

* v4.25 * Update src/main/webapp/app/config/constants.tsx Co-authored-by: Calvin Lu <[email protected]> --------- Co-authored-by: Calvin Lu <[email protected]>
oncokb · Jan 30, 2025 · 8ec6040 · 8ec6040
1 parent 200a3da
commit 8ec6040
Show file tree

Hide file tree

Showing 5 changed files with 201 additions and 49 deletions.
diff --git a/src/main/webapp/app/config/constants.tsx b/src/main/webapp/app/config/constants.tsx
@@ -866,6 +866,7 @@ export type DataRelease = {
 };
 
 export const DATA_RELEASES: DataRelease[] = [
+  { date: '01302025', version: 'v4.25' },
   { date: '12192024', version: 'v4.24' },
   { date: '11262024', version: 'v4.23' },
   { date: '10242024', version: 'v4.22' },

diff --git a/src/main/webapp/app/pages/newsPage/NewsPage.tsx b/src/main/webapp/app/pages/newsPage/NewsPage.tsx
@@ -86,6 +86,7 @@ export default class NewsPage extends React.Component<{
           <CitationText />
         </div>
         <div className="mt-2">
+          <NewsList date={'01302025'} />
           <NewsList date={'12192024'} />
           <NewsList date={'11262024'} />
           <NewsList date={'10242024'} />

diff --git a/src/main/webapp/app/pages/newsPage/NewsPageContent.tsx b/src/main/webapp/app/pages/newsPage/NewsPageContent.tsx
@@ -301,6 +301,144 @@ const EVIDENCE_COLUMN_SEPARATOR = '; ';
 // https://stackoverflow.com/questions/41947168/is-it-possible-to-use-keyof-operator-on-literals-instead-of-interfaces
 
 export const NEWS_BY_DATE: { [date: string]: NewsData } = {
+  '01302025': {
+    priorityNews: [
+      <span>
+        Happy New Year! As of January 30th, 2025, fifteen Level 1, twelve Level
+        2, eighteen Level 3 and eleven Level 4 treatments for unique
+        biomarker-selected indications were added to OncoKB. A table summarizing
+        these changes can be found here{' '}
+        <YearEndReviewPageLink year={'2024'}>here</YearEndReviewPageLink>. The
+        “Precision Oncology: 2024 in Review” article can be found{' '}
+        <Linkout
+          link={
+            'https://aacrjournals.org/cancerdiscovery/article/14/12/2332/750142/Precision-Oncology-2024-in-ReviewPrecision'
+          }
+        >
+          here
+        </Linkout>
+        .
+      </span>,
+    ],
+    changedAnnotations: [
+      {
+        columnHeaderType: AnnotationColumnHeaderType.NEW_ALTERATION_WITH_LEVEL,
+        content: [
+          [
+            '2',
+            'ERBB2',
+            'Oncogenic Mutations',
+            'Cervical Cancer',
+            'Neratinib',
+            [
+              <WithSeparator separator={EVIDENCE_COLUMN_SEPARATOR}>
+                <span>
+                  Inclusion in Cervical Cancer NCCN Guidelines V1.2025
+                </span>
+                <PMIDLink pmids="38211393" />
+              </WithSeparator>,
+            ],
+          ],
+        ],
+      },
+      {
+        columnHeaderType:
+          AnnotationColumnHeaderType.PROMOTION_TUMOR_TYPE_SPECIFIC_EVIDENCE,
+        content: [
+          [
+            'KRAS',
+            'G12C',
+            'Small Bowel Cancer',
+            <div>
+              <div style={{ fontStyle: 'italic' }}>
+                {DRUGS_PROMOTED_IN_ONCOKB}:
+              </div>
+              <div>Adagrasib (Level 2, previously Level 3A)</div>
+              <br></br>
+              <div style={{ fontStyle: 'italic' }}>
+                {DRUGS_ADDED_TO_ONCOKB}:
+              </div>
+              <div>Sotorasib (Level 2)</div>
+            </div>,
+            '3A',
+            '2',
+            <WithSeparator separator={EVIDENCE_COLUMN_SEPARATOR}>
+              <span>
+                Inclusion in Small Bowel Adenocarcinoma NCCN Guidelines V1.2025
+              </span>
+              <PMIDLink pmids="32955176, 37099736, 36546659, 34919824" />
+            </WithSeparator>,
+          ],
+        ],
+      },
+      {
+        columnHeaderType: AnnotationColumnHeaderType.UPDATED_SAME_LEVEL_DRUG,
+        content: [
+          [
+            '1',
+            'ALK',
+            <WithSeparator separator={', '}>
+              <AlterationPageLink hugoSymbol="ALK" alteration="Fusions">
+                Fusions
+              </AlterationPageLink>
+            </WithSeparator>,
+            'Non-Small Cell Lung Cancer',
+            <div>
+              <div>
+                Alectinib, Brigatinib, Certinib, Crizotinib, Lorlatinib (Level
+                1)
+              </div>
+              <br />
+              <div>NVL-655 (Level 3A)</div>
+            </div>,
+            'Ensartinib (Level 1)',
+            <WithSeparator separator={EVIDENCE_COLUMN_SEPARATOR}>
+              <FdaApprovalLink
+                approval="ensartinib"
+                link="https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ensartinib-alk-positive-locally-advanced-or-metastatic-non-small-cell-lung-cancer"
+              />
+              <PMIDLink pmids="34473194" />
+            </WithSeparator>,
+          ],
+          [
+            '1',
+            'KRAS',
+            <WithSeparator separator={', '}>
+              <AlterationPageLink hugoSymbol="KRAS" alteration="G12C">
+                G12C
+              </AlterationPageLink>
+            </WithSeparator>,
+            'Colorectal Cancer',
+            <div>
+              <div style={{ textDecoration: 'underline' }}>Sensitivity</div>
+              <div>Adagrasib + Cetuximab (Level 1)</div>
+              <br />
+              <div>
+                Adagrasib + Panitumumab, Sotorasib + Cetuximab, Sotorasib +
+                Panitumumab (Level 2)
+              </div>
+              <br />
+              <div>Binimetinib, Cobimetinib, Trametinib (Level 4)</div>
+              <br />
+              <div style={{ textDecoration: 'underline' }}>Resistance</div>
+              <div>
+                Cetuximab, Panitumumab, Tucatinib + Trastuzumab (Level R1)
+              </div>
+            </div>,
+            'Sotorasib + Panitumumab (Level 1)',
+            <WithSeparator separator={EVIDENCE_COLUMN_SEPARATOR}>
+              <FdaApprovalLink
+                approval="sotorasib with panitumumab"
+                link="https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-sotorasib-panitumumab-kras-g12c-mutated-colorectal-cancer"
+              />
+              <PMIDLink pmids="37870968" />
+            </WithSeparator>,
+          ],
+        ],
+      },
+    ],
+    newlyAddedGenes: ['AKT1S1', 'ALOX15B'],
+  },
   '12192024': {
     priorityNews: [
       <span>